Consumer Research
New Menopause Guide Unlocks the Power of Major Cannabinoids
HONOLULU – As demand for Cannabis and hemp-based wellness products ...
GTI Bets on Its Own Stock, Again
CHICAGO – Green Thumb Industries Inc. announced that its board ...
Vireo Growth Completes M3 Wellness Acquisition
MINNEAPOLIS – Vireo Growth Inc. announced the completion of its ...
Definium Achieves Second Positive Phase 3 for GAD
NEW YORK – Definium Therapeutics Inc. released topline data from its second pivotal Phase 3 trial (Panorama study) of DT120 in generalized anxiety disorder (GAD), adding to earlier positive findings in the same indication and ...
High Tide Reports Q3 2026 Financial Results
CALGARY – High Tide Inc. posted revenue of $198.8 million for the three months ended July 31, 2026, a 33% increase from the same period last year and the fifth consecutive quarterly record. Gross profit ...
Curaleaf Escalates Aurora Fight, Asks Alberta Regulator to Freeze Share Sales
STAMFORD – Curaleaf Holdings Inc. submitted a formal application to the Alberta Securities Commission (ASC), seeking to halt Aurora Cannabis's at-the-market share issuance program while Curaleaf's offer to acquire all outstanding Aurora shares remains outstanding. ...
NEWS: Psilocybin Could Help Prevent Debilitating Nerve Damage Caused by Chemotherapy
AUSTIN – A new study from The University of Texas MD Anderson Cancer Center suggests that psilocybin, the psychedelic compound found in certain mushrooms, could eventually help prevent one of chemotherapy’s most painful and persistent side ...
Elixinol Offloads Its US Hemp Business to Ananda Health
SYDNEY – Australian Elixinol Wellness Limited has entered into a binding asset purchase agreement with Ananda Health to sell its wholly-owned subsidiary, Elixinol LLC, effectively exiting the United States hemp market. Under the transaction terms, ...
ARPA-H Launches ASCENT-IBO Initiative for Ibogaine Clinical Research
WASHINGTON – The Advanced Research Projects Agency for Health (ARPA-H) has launched a federal research opportunity aimed at accelerating clinical evaluations of ibogaine for Opioid Use Disorder (OUD). Titled ASCENT-IBO, short for Accelerating Safe Clinical ...
cbdMD Moves to Acquire Twinlab
CHARLOTTE – cbdMD, Inc. entered into a definitive asset purchase agreement to acquire the operating assets and brands of Twinlab, including Twinlab, Reserveage, Metabolife and Alvita Tea. The transaction is structured through an assignment for ...
Eli Lilly Completes Acquisition of AtaiBeckley
INDIANAPOLIS – Eli Lilly & Co. has closed its acquisition of AtaiBeckley Inc., the New York-based biopharmaceutical company developing psychedelic-derived therapies for treatment-resistant mental health conditions. The transaction cleared its final U.S. regulatory checkpoint when ...
Curaleaf Fires Back at Aurora Claims with Detailed Fact Sheet
STAMFORD – Curaleaf Holdings Inc. released a 14-point public fact sheet taking direct aim at what it described as misleading statements Aurora Cannabis Inc. has circulated in opposition to Curaleaf's unsolicited bid to acquire the ...
Cannaflex Opens European Export Route
RABAT – Moroccan operator Cannaflex has secured EU-GMP compliance verification for the commercial export of medical Cannabis starting materials to Switzerland and broader European markets, marking an operational milestone for the Kingdom's legal framework. Working ...
Vireo Growth Reports Q1 2026 Financial Results
MINNEAPOLIS – Vireo Growth Inc. released its first-quarter 2026 financial results, highlighting the early effects of an active acquisition strategy that has broadened its operations across several key Cannabis markets. The company, which operates a ...
Village Farms Reports Q1 2026 Financial Results
VANCOUVER – Village Farms International Inc., known for its large-scale greenhouse operations, reported gains in revenue and profitability driven largely by exports. Consolidated net sales climbed 27% year-over-year to $50.2 million, with net income attributable ...
Israeli Cannabis Breakthrough Opens New Hope for Fatty Liver Disease
NEW YORK- A new study out of Israel has put Cannabis back into one of the most important conversations in modern medicine: metabolic disease. Researchers at the Hebrew University of Jerusalem have reported that two ...
Why the Endocannabinoid System Is the Future of Cannabis Medicine
NEW YORK- Cannabis medicine is entering a more serious phase. For years, the conversation has focused on pain, sleep, anxiety, appetite, and symptom relief. Those remain important, but they may only be the beginning. The ...
Cannabis, Inflammation, and the Next Frontier in Root-Cause Medicine
NEW YORK- Cannabis medicine is moving beyond pain, sleep, and anxiety. One of the most important next frontiers may be inflammation, because the endocannabinoid system plays a direct role in how the body regulates immune ...
Why Metabolic Dysfunction May Be the Next Frontier for Cannabinoid Medicine
NEW YORK- Metabolism is the system that determines how the body produces, distributes, and uses energy, and it sits at the center of modern chronic disease. While it is often reduced to a discussion of ...
Cresco Labs Reports Q1 2026 Financial Results
CHICAGO – Cresco Labs Inc. released its first-quarter results, showcasing the ongoing efforts of one of the largest MSOs to strengthen operations across its footprint while preparing for potential changes at the federal level. With ...
Cronos Group Reports Q1 2026 Financial Results
TORONTO – Cronos Group Inc. posted record net revenue and gross profit for the first quarter of 2026, driven by higher sales volumes, a favorable product mix, and gains in key markets. The Cannabis company ...
Week in Review: Cannabis & Psychedelics Industry Highlights
LOS ANGELES – The past two weeks brought measurable movement across federal policy, corporate financial reporting, international deals, and product categories in the U.S. Cannabis sector. Operators absorbed details on rescheduling implications, watched hemp-derived THC ...
Congress Presses FDA on Psychedelic Therapy Approvals
WASHINGTON – A bipartisan coalition of 32 House members sent a formal letter to FDA Commissioner Martin A. Makary urging the agency to move faster on ongoing reviews of psychedelic treatments. The letter stated that ...
TerrAscend Reports Q1 2026 Financial Results
TORONTO – TerrAscend Corp. announced financial results for the first quarter ended March 31, 2026, showing modest year-over-year revenue growth from continuing operations and sustained operational performance across its core Northeast markets. The company reported ...
Trulieve Reports Q1 2026 Financial Results
TALLAHASSEE – Trulieve Cannabis Corp. entered 2026 with a first quarter that presents two concurrent narratives – a retail operation contending with sustained pricing pressure, and a company whose federal tax obligations are, for the ...
LEEF Brands Reports Q1 2026 Financial Results
VANCOUVER – LEEF Brands Inc. reported its strongest financial quarter since inception, showing marked operational progress and turning what had been a loss position a year ago into meaningful profitability, all without adding a single ...
GTI Reports Q1 2026 Financial Results
CHICAGO – Green Thumb Industries Inc. released its first-quarter 2026 financial results, highlighting steady performance in a market still marked by price competition and variable demand. The multistate Cannabis operator posted steady revenue growth, alongside ...
Target Expands Hemp-Derived THC Beverage Sales Area
NEW YORK – Target is broadening its reach in the hemp-derived THC beverage category, adding the products to more than 300 stores across Florida, Texas and parts of Illinois. The mass retailer confirmed the move ...
Cannara Biotech Wraps Up Medican Organic Acquisition
MONTREAL – Cannara Biotech Inc. announced the closing of a transaction to acquire all of the shares of Medican Organic Inc. for an aggregate purchase price of $2.8 million. On the surface, that's a modest ...
Aprio Targets Cannabis Sector in Price Kong Acquisition
ATLANTA-PHOENIX – Aprio, the 20th largest business advisory and accounting firm in the United States, announced it had entered into an agreement to acquire Price Kong, a Phoenix-based CPA and advisory firm. The transaction, effective ...
RYTHM Reports Q1 2026 Financial Results
ROLLING MEADOWS – RHYTHM Inc. disclosed stronger results for the first quarter of 2026 as the company continued its shift toward branded hemp-derived THC products and licensing deals. Revenue from continuing operations came in at ...
High Tide Scores Big in Germany Through Remexian Distribution
CALGARY-BERLIN – High Tide Inc. reported that its majority-owned German subsidiary, Remexian Pharma GmbH, distributed 7.6 tons of medical Cannabis flower into the German market during the second fiscal quarter ended April 30, 2026 – ...
Curaleaf Reports Q1 2026 Financial Results
STAMFORD – Curaleaf Holdings Inc. posted its strongest revenue growth in years during the first quarter of 2026, swinging to a net profit just as the federal regulatory environment under which the industry operates began ...
LeafLink Releases 2026 Wholesale Cannabis Pricing Guide
NEW YORK – LeafLink, a unified B2B marketplace and technology platform built specifically for the Cannabis industry, published its annual 2026 Wholesale Cannabis Pricing Guide, delivering one of the most comprehensive data snapshots the legal ...
Psilocybin Shows Promise for Those Ready to Break Free from Nicotine
BALTIMORE – Researchers at Johns Hopkins University have published findings from a pilot randomized clinical trial that points to potential advantages of psilocybin-assisted therapy over standard nicotine replacement for helping adults quit cigarettes. Published in ...
Hall of Flowers Relocates Northern California Event to Sacramento
LOS ANGELES – After eight years in Santa Rosa, the B2B Cannabis trade show Hall of Flowers is moving its Northern California event to the Cal Expo exhibition halls in Sacramento. The newly confirmed dates, ...
Vireo to Acquire FLUENT in All-Stock Deal
LOS ANGELES – Vireo Growth Inc. announced it has signed a definitive agreement to absorb FLUENT Corp. in an all-stock transaction, a deal that, if approved, would make Vireo the third-largest operator in medical-only Florida's ...
DEA Assigns Specific Schedule I Listing and Drug Code to HHC
WASHINGTON – The Drug Enforcement Administration (DEA) has issued a final rule that formally lists hexahydrocannabinol (HHC) as a Schedule I controlled substance with its own dedicated drug code. The notice, published in the Federal ...
